pharma · CACNA1A Disorders · Niemann-Pick disease type C
IntraBio
Intrabio Ireland Limited
IntraBio clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Austin, USA
- Employees
- 44
- Programs
- 3
- Drugs
- 3
- Patents
- 0
IntraBio projects
3 ClinicalTrials.gov programs sponsored by IntraBio.
IntraBio has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Granules for oral suspension, N-Acetyl-L-Leucine
Intrabio Ireland Limited
Niemann-Pick disease type C
1 trial -
N-Acetyl-L-Leucine, granules for suspension
Intrabio Ireland Limited
CACNA1A Disorders
1 trial -
granules for suspension, N-Acetyl-L-Leucine
Intrabio Ireland Limited
Ataxia Telangiectasia
1 trial
Frequently asked questions
How many clinical projects does IntraBio have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.